Remission of malabsorption in congenital intestinal lymphangiectasia following chemotherapy for lymphoma.
A 22-year-old female with protein losing enteropathy due to congenital intestinal lymphangiectasia who developed non-Hodgkin's lymphoma of the bone, is described. Complete remission of the lymphomatous process and disappearance of the gastrointestinal symptoms were achieved following treatment with combination chemotherapy and local irradiation.
Shpilberg
O
O
Institute of Hematology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Shimon
I
I
Bujanover
Y
Y
Ben-Bassat
I
I
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008201:Lymphangiectasis, Intestinal / Q000150:complications*; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008286:Malabsorption Syndromes / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone